ApicHope Pharmaceutical Group Co., Ltd. (SHE:300723)

China flag China · Delayed Price · Currency is CNY
35.95
-0.56 (-1.53%)
May 9, 2025, 3:04 PM CST
52.07%
Market Cap 16.14B
Revenue (ttm) 1.20B
Net Income (ttm) -583.96M
Shares Out 449.03M
EPS (ttm) -1.29
PE Ratio n/a
Forward PE 85.60
Dividend 0.21 (0.59%)
Ex-Dividend Date Jun 3, 2024
Volume 8,760,639
Average Volume 16,233,145
Open 39.30
Previous Close 36.51
Day's Range 35.90 - 39.30
52-Week Range 12.74 - 42.42
Beta 0.67
RSI 53.77
Earnings Date Apr 25, 2025

About SHE:300723

ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research and development, production, and sale of pharmaceutical drugs. Its pediatric medicines include fuganlin and yiqi jianpi oral liquid, carboxymestrine oral solution, and xiaoer kechuanling oral liquid products; and clindamycin hydrochloride palmitate dispersible tablet, acetylguitaricin dry suspension, qinxiangqingjie oral liquid, levocetirizine hydrochloride drop, epstein hydrochloride granule, clindamycin hydrochloride palmitate granule, clindamycin... [Read more]

Sector Healthcare
Founded 2002
Employees 1,484
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300723
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.